ACT NOW

Serial Number 77669887
602

Registration Progress

Application Filed
Feb 13, 2009
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

ACT NOW

Basic Information

Serial Number
77669887
Filing Date
February 13, 2009
Abandonment Date
April 20, 2010
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
May 17, 2010
Classes
041

Rights Holder

Hoffmann-La Roche Inc.

03
Address
340 Kingsland Street
Nutley, NJ 07110

Ownership History

Hoffmann-La Roche Inc.

Original Applicant
03
Nutley, NJ

Legal Representation

Attorney
Lorraine M. Anderson

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

18 events
Date Code Type Description Documents
May 17, 2010 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
May 17, 2010 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Nov 19, 2009 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Nov 18, 2009 ALIE A ASSIGNED TO LIE Loading...
Nov 18, 2009 ALIE A ASSIGNED TO LIE Loading...
Nov 6, 2009 MAIL I PAPER RECEIVED Loading...
Oct 19, 2009 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 19, 2009 GNRT O NON-FINAL ACTION E-MAILED Loading...
Oct 19, 2009 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 24, 2009 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 24, 2009 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 24, 2009 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 26, 2009 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 26, 2009 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 26, 2009 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 26, 2009 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 18, 2009 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 17, 2009 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 041
Education services, namely, online information, directed to healthcare practitioners and patients on the risks and benefits associated with a pharmaceutical preparation to treat rheumatoid arthritis
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
041